Published in Arthritis Rheum on December 15, 2008
Impact of self-rated osteoarthritis severity in an employed population: cross-sectional analysis of data from the national health and wellness survey. Health Qual Life Outcomes (2012) 0.99
The effect of disease site (knee, hip, hand, foot, lower back or neck) on employment reduction due to osteoarthritis. PLoS One (2010) 0.90
The personal and national costs of lost labour force participation due to arthritis: an economic study. BMC Public Health (2013) 0.85
Productivity at work and quality of life in patients with rheumatoid arthritis. BMC Musculoskelet Disord (2015) 0.83
Tension at the borders: perceptions of role overload, conflict, strain and facilitation in work, family and health roles among employed individuals with arthritis. Rheumatology (Oxford) (2011) 0.82
Striking a balance: work-health-personal life conflict in women and men with arthritis and its association with work outcomes. J Occup Rehabil (2014) 0.81
Impact and therapy of osteoarthritis: the Arthritis Care OA Nation 2012 survey. Clin Rheumatol (2014) 0.81
Arthritis has an impact on the daily lives of Canadians young and old: results from a population-based survey. BMC Musculoskelet Disord (2015) 0.75
Role overload, pain and physical dysfunction in early rheumatoid or undifferentiated inflammatory arthritis in Canada. Biopsychosoc Med (2012) 0.75
Work instability in rheumatoid arthritis patients from Argentina: prevalence and associated factors. Rheumatol Int (2014) 0.75
Labour force participation and the influence of having arthritis on financial status. Rheumatol Int (2015) 0.75
How co-morbidities magnify the effect of arthritis on labour force participation and economic status: a costs of illness study in Australia. Rheumatol Int (2014) 0.75
The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health (2009) 9.79
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum (2008) 4.20
Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med (2013) 3.51
Critical shortage of orthopaedic services in Ontario, Canada. J Bone Joint Surg Am (2003) 3.40
Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis. Ann Intern Med (2009) 3.03
Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis (2012) 2.24
Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum (2005) 2.20
Long-term (10-year) mortality of younger previously healthy patients with severe sepsis/septic shock is worse than that of patients with nonseptic critical illness and of the general population. Crit Care Med (2014) 2.19
Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. CMAJ (2003) 2.18
Safety and efficiency of emergency department assessment of chest discomfort. CMAJ (2004) 2.09
A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med (2005) 2.07
Barriers to providing adequate rheumatology care: implications from a survey of rheumatologists in ontario, Canada. J Rheumatol (2002) 2.04
A prospective population-based study of the predictors of undergoing total joint arthroplasty. Arthritis Rheum (2006) 1.82
Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city. J Rheumatol (2011) 1.75
Intensive care unit admission has minimal impact on long-term mortality. Crit Care Med (2002) 1.73
The effect of education and income on need and willingness to undergo total joint arthroplasty. Arthritis Rheum (2002) 1.73
Understanding social role participation: what matters to people with arthritis? J Rheumatol (2008) 1.71
Ambulatory physician care for musculoskeletal disorders in Canada. J Rheumatol (2006) 1.70
"What do you expect? You're just getting older": A comparison of perceived osteoarthritis-related and aging-related health experiences in middle- and older-age adults. Arthritis Rheum (2006) 1.69
Productivity loss due to presenteeism among patients with arthritis: estimates from 4 instruments. J Rheumatol (2010) 1.64
Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study. Addiction (2012) 1.62
Time to disease-modifying antirheumatic drug treatment in rheumatoid arthritis and its predictors: a national, multicenter, retrospective cohort. J Rheumatol (2012) 1.60
Perceptions of, and willingness to consider, total joint arthroplasty in a population-based cohort of individuals with disabling hip and knee arthritis. Arthritis Rheum (2004) 1.57
Effect of sociodemographic factors on surgical consultations and hip or knee replacements among patients with osteoarthritis in British Columbia, Canada. J Rheumatol (2010) 1.57
The relationship between osteoarthritis and cardiovascular disease in a population health survey: a cross-sectional study. BMJ Open (2013) 1.55
Managing arthritis and employment: making arthritis-related work changes as a means of adaptation. Arthritis Rheum (2004) 1.54
Workplace, psychosocial factors, and depressive symptoms among working people with arthritis: a longitudinal study. J Rheumatol (2006) 1.54
Expanding roles in orthopaedic care: a comparison of physiotherapist and orthopaedic surgeon recommendations for triage. J Eval Clin Pract (2009) 1.53
Measuring and valuing productivity loss due to poor health: A critical review. Soc Sci Med (2010) 1.52
Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications. Pharmacoeconomics (2005) 1.50
Evaluation of an inter-professional educational intervention to improve the use of arthritis best practices in primary care. J Rheumatol (2011) 1.46
Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006. J Subst Abuse Treat (2010) 1.44
Early management of newly diagnosed rheumatoid arthritis by Canadian rheumatologists: a national, multicenter, retrospective cohort. J Rheumatol (2011) 1.43
When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions. CMAJ (2005) 1.42
Cost-effectiveness: cholinesterase inhibitors and memantine in vascular dementia. Can J Neurol Sci (2009) 1.41
Pain as a mediator of sleep problems in arthritis and other chronic conditions. Arthritis Rheum (2005) 1.39
Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment. CMAJ (2012) 1.37
A population-based nested case-control study of the costs of hip and knee replacement surgery. Med Care (2009) 1.35
Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. Arthritis Rheum (2008) 1.33
Which patients are most likely to benefit from total joint arthroplasty? Arthritis Rheum (2013) 1.28
A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Med Care (2004) 1.27
Descriptive epidemiology of osteoarthritis in British Columbia, Canada. J Rheumatol (2006) 1.27
HIV-positive injection drug users who leave the hospital against medical advice: the mitigating role of methadone and social support. J Acquir Immune Defic Syndr (2004) 1.27
Validity of the work productivity and activity impairment questionnaire--general health version in patients with rheumatoid arthritis. Arthritis Res Ther (2010) 1.26
Proportional hazards frailty models for recurrent methadone maintenance treatment. Am J Epidemiol (2009) 1.26
2013 ACC/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol (2014) 1.21
The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review. J Rheumatol (2008) 1.20
Revisiting arthritis prevalence projections--it's more than just the aging of the population. J Rheumatol (2006) 1.18
The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work. Med Care (2006) 1.17
Approval process and access to prescription drugs in Canada. Arthritis Rheum (2006) 1.15
Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum (2011) 1.14
Adaptation to disability: applying selective optimization with compensation to the behaviors of older adults with osteoarthritis. Psychol Aging (2002) 1.14
Importance of self-rated health and mental well-being in predicting health outcomes following total joint replacement surgery for osteoarthritis. Arthritis Care Res (Hoboken) (2011) 1.14
Effects of use of specialty services on disease-modifying antirheumatic drug use in the treatment of rheumatoid arthritis in an insured elderly population. Med Care (2004) 1.12
Risk of cardiovascular disease in patients with osteoarthritis: a prospective longitudinal study. Arthritis Care Res (Hoboken) (2013) 1.10
Infliximab treatment of rheumatoid arthritis and Crohn's disease. Ann Pharmacother (2003) 1.10
Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheumatology (Oxford) (2012) 1.10
Beyond access: who reports that health care is not being received when needed in a publicly-funded health care system? Can J Public Health (2004) 1.10
Trends in physician-diagnosed osteoarthritis incidence in an administrative database in British Columbia, Canada, 1996-1997 through 2003-2004. Arthritis Rheum (2008) 1.10
Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review. Br J Clin Pharmacol (2014) 1.09
Proxy reporting and the increasing prevalence of arthritis in Canada. Can J Public Health (2004) 1.09
Health related quality of life trajectories of patients in opioid substitution treatment. Drug Alcohol Depend (2011) 1.09
Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Qual Life Res (2005) 1.08
Worker productivity outcome measures in arthritis. J Rheumatol (2007) 1.08
Consensus statements for the use of administrative health data in rheumatic disease research and surveillance. J Rheumatol (2012) 1.06
Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol (2008) 1.05
Systematic review and meta-analysis of validation studies on a diabetes case definition from health administrative records. PLoS One (2013) 1.05
Participation restrictions among older adults with osteoarthritis: a mediated model of physical symptoms, activity limitations, and depression. Arthritis Rheum (2008) 1.05
Usability testing of ANSWER: a web-based methotrexate decision aid for patients with rheumatoid arthritis. BMC Med Inform Decis Mak (2013) 1.04
Fatigue in osteoarthritis: a qualitative study. BMC Musculoskelet Disord (2008) 1.04
Reliability, validity, and responsiveness of five at-work productivity measures in patients with rheumatoid arthritis or osteoarthritis. Arthritis Care Res (Hoboken) (2010) 1.02
Arthritis onset and worsening self-rated health: a longitudinal evaluation of the role of pain and activity limitations. Arthritis Rheum (2005) 1.02
Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine. J Rheumatol (2002) 1.01
Association of regional racial/cultural context and socioeconomic status with arthritis in the population: a multilevel analysis. Arthritis Rheum (2008) 1.00
Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents. J Rheumatol (2004) 1.00
Health care utilization for musculoskeletal disorders. Arthritis Care Res (Hoboken) (2010) 1.00
An evidence-informed, integrated framework for rheumatoid arthritis care. Arthritis Rheum (2008) 0.99
The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities. Health Policy (2006) 0.99
Characteristics of evolving models of care for arthritis: a key informant study. BMC Health Serv Res (2008) 0.99
Systematic review of validation studies of the use of administrative data to identify serious infections. Arthritis Care Res (Hoboken) (2013) 0.98
"Should I tell my employer and coworkers I have arthritis?" A longitudinal examination of self-disclosure in the work place. Arthritis Rheum (2009) 0.98
Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment. Arthritis Res Ther (2010) 0.97
Predictors of early hospital readmission in HIV-infected patients with pneumonia. J Gen Intern Med (2003) 0.97
The economic burden of rheumatoid arthritis: beyond health care costs. Clin Rheumatol (2011) 0.97
Occurrence of radiographic osteoarthritis of the knee and hip among African Americans and whites: a population-based prospective cohort study. Arthritis Care Res (Hoboken) (2013) 0.97
A population-based study of ambulatory and surgical services provided by orthopaedic surgeons for musculoskeletal conditions. BMC Health Serv Res (2009) 0.97
Characterizing self-rated health during a period of changing health status. Soc Sci Med (2010) 0.97
Consistent low prevalence of arthritis in quebec: findings from a provincial variation study in Canada based on several canadian population health surveys. J Rheumatol (2003) 0.96
Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis (2011) 0.96
Magnitude of impact and healthcare use for musculoskeletal disorders in the paediatric: a population-based study. BMC Musculoskelet Disord (2012) 0.95
Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study. Ann Rheum Dis (2011) 0.95